BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/9/2021 6:46:56 AM | Browse: 348 | Download: 614
 |
Received |
|
2021-01-06 13:44 |
|
Peer-Review Started |
|
2021-01-06 13:45 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-05-05 22:18 |
|
Revised |
|
2021-05-15 09:29 |
|
Second Decision |
|
2021-07-29 02:54 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-07-29 08:06 |
|
Articles in Press |
|
2021-07-29 08:06 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-08-17 21:14 |
|
Typeset the Manuscript |
|
2021-09-02 03:46 |
|
Publish the Manuscript Online |
|
2021-09-09 06:46 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yin-Lian Wu, Rahul Kumar, Ming-Fang Wang, Medha Singh, Jiao-Feng Huang, Yue-Yong Zhu and Su Lin |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Chinese National 13th Five-Year Plan's Science and Technology Projects |
2017ZX10202201 |
|
| Corresponding Author |
Su Lin, MD, PhD, Associate Chief Physician, Professor, Department of Hepatology, Hepatology Research Institute, The First Affiliated Hospital, Fujian Medical University, No. 20 Chazhong Road, Taijiang District, Fuzhou 350005, Fujian Province, China. sumer5129@fjmu.edu.cn |
| Key Words |
Metabolic associated fatty liver disease; Non-invasive fibrosis scores; Fibrosis-4 index; Non-alcoholic fatty liver disease fibrosis score; Aspartate aminotransferase to platelet ratio index; BARD |
| Core Tip |
Metabolic associated fatty liver disease (MAFLD) is a new concept proposed in 2020 to re-define fatty liver disease. The utility of non-invasive fibrosis scores as well as their optimal thresholds for MAFLD remains unknown. We validated the conventional non-invasive scores including aspartate aminotransferase to platelet ratio index, fibrosis-4 index, diabetes score (BARD), and non-alcoholic fatty liver disease fibrosis score in patients with MAFLD. The results indicate that the conventional scores may lead to a high rate of misdiagnosis in MAFLD. Novel scoring system for fibrosis is urgently needed. |
| Publish Date |
2021-09-09 06:46 |
| Citation |
Wu YL, Kumar R, Wang MF, Singh M, Huang JF, Zhu YY, Lin S. Validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease. World J Gastroenterol 2021; 27(34): 5753-5763 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i34/5753.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i34.5753 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
